Progress of MLL-PTD mutation in acute myeloid leukemia
10.3760/cma.j.cn115356-20231127-00086
- VernacularTitle:伴MLL-PTD突变在急性髓系白血病中的研究进展
- Author:
Kainan ZHANG
1
;
Xiaosu ZHAO
Author Information
1. 北京大学人民医院 北京大学血液病研究所 国家血液系统疾病临床医学研究中心 造血干细胞移植治疗血液病北京市重点实验室,北京 100044
- Keywords:
Leukemia, myeloid, acute;
MLL-PTD gene;
Gene mutation;
Prognosis
- From:
Journal of Leukemia & Lymphoma
2025;34(3):181-185
- CountryChina
- Language:Chinese
-
Abstract:
Acute myeloid leukemia (AML) is a clonal malignant proliferative blood disease, which has a wide range of genomic changes and molecular mutations. The human mixed-linage leukemia (MLL) gene can produce partial tandem duplications (MLL-PTD), which is associated with a poor prognosis. This paper elaborates on the pathogenesis of MLL-PTD and its mechanism as well as therapeutic targets.